Clinical trial
Safety and Efficacy Evaluation of Cryoablation for Ground-Glass Nodules: A Single-Arm, Prospective, Open-Label Clinical Study
NCT07232433 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Evaluation of Cryoablation for Ground-Glass Nodules: A Single-Arm, Prospective, Open-Label Clinical Study
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 21, 2025
- Completion date
- October 31, 2030
- Enrollment
- 90 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer